Tryptase in drug-induced anaphylaxis: the need for acute and baseline values
- PMID: 39079161
- DOI: 10.1097/ACI.0000000000001012
Tryptase in drug-induced anaphylaxis: the need for acute and baseline values
Abstract
Purpose of review: The purpose of this narrative review was to summarize data and official recommendations purporting to paired tryptase determination in patients experiencing drug-induced anaphylaxis, published between January 1, 2023 and June 1, 2024.
Recent findings: Three main lines of evidence obtained through paired acute and baseline tryptase determination were identified: diagnostic criterion for hypersensitivity reactions involving systemic mast cell activation; differential diagnostic criterion for hypersensitivity reactions involving other mechanisms of immediate reactions; and added value of acute and baseline tryptase levels for personalized management following drug-induced anaphylaxis: cause, risk of recurrence, underlying mast cell conditions including hereditary α-tryptasemia, familial clusters.
Summary: The implementation of existing guidelines which consensually recommend paired tryptase measurement is a persistent unmet need hampering optimal diagnosis of drug-induced anaphylaxis and patient management. Another major unmet need is the lack of standardized recommendations for hereditary α-tryptasemia testing and counselling. Progress in this field is seen at a rapid pace, requiring significant efforts of continued medical education for practicing clinicians and laboratory specialists worldwide.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Hofer V, Dolle-Bierke S, Francuzik W, et al. Fatal and near-fatal anaphylaxis: data from the European Anaphylaxis Registry and National Health Statistics. J Allergy Clin Immunol Pract 2024; 12:96–105. e108.
-
- Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: A 2023 practice parameter update. Ann Allergy Asthma Immunol 2024; 132:124–176.
-
- Pouessel G, Tacquard C, Tanno LK, et al. Anaphylaxis mortality in the perioperative setting: epidemiology, elicitors, risk factors and knowledge gaps. Clin Exp Allergy 2024; 54:11–20.
-
- Muraro A, Worm M, Alviani C, et al. EAACI guidelines: anaphylaxis (2021 update). Allergy 2022; 77:357–377.
-
- Alvarez-Arango S, Kumar M, Chow TG, Sabato V. Non-IgE-mediated immediate drug-induced hypersensitivity reactions. J Allergy Clin Immunol Pract 2024; 12:1109–1119.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials